A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

NCT05488340 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

318

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections

Interventions

DRUG: LBP-EC01 0.1 x IV dose
DRUG: LBP-EC01 0.01x IV Dose
DRUG: LBP-EC01 IV Infusion Dose
DRUG: Placebo
DRUG: LBP-EC01
DRUG: TMP/SMX

Sponsor

Locus Biosciences

Collaborators

Parexel